Table 3.

Clinical trials evaluating the effects of V. myrtillus on metabolic disorders. This table is compiled from the information available at https://www.clinicaltrials.gov/, accessed on 9 August 2023.

NCT Number	Study Title	Clinical Trial Status	Study Design	Condition	References
NCT01860547	The Effect of the Bioactives of Sea Buckthorn and Bilberry on the Risk of Metabolic Diseases	Not applicable	Randomized, open-label, crossover assignment	Type 2 Diabetes Atherosclerosis	[105]
NCT01414647	The Effect of Diet Rich in Nordic Berries on Gut Microbiota, Glucose and Lipid Metabolism and Metabolism on Fenolic Compounds	Not applicable	Randomized, open-label, crossover assignment	Metabolic Syndrome Impaired Glucose Tolerance Low-grade Inflammation Dyslipidemia	[106]
NCT03415503	Anthocyanin Supplementation Improves Blood Lipids in a Dose-response Manner in Subjects with Dyslipidemia	Phase 3	Randomized, double-blind (participant, investigator), parallel assignment	Dyslipidemia	[107]
NCT04054284	Safety and Efficacy of a Complex Herbal Tea Mixture in Type 2 Diabetics	Not applicable	Randomized, quadruple -blind (participant, care provider, investigator, outcomes assessor), parallel assignment	Type 2 Diabetes	[108]